Introduction
Adenosine A 2A receptor antagonists represent a class of non dopamine related drugs which are being tested for their ecacy in the treatment of Parkinson's Disease (Richardson et al., 1997) . However the mechanism of action of such drugs is unclear, and in particular the possible involvement of such receptors on striatal cholinergic interneurons is debatable (Fredholm & Svenningsson, 1998; Richardson et al., 1998) . Indeed, there are a number of discrepancies in the literature relating to the expression and function of adenosine A 1 and A 2A receptors in these neurons.
The adenosine A 1 receptor has been shown to inhibit ACh release from striatal cholinergic nerve terminals (Brown et al., 1990) , and the adenosine A 2A receptor has been shown to stimulate acetylcholine release from striatal synaptosomes (Brown et al., 1990; Kurokawa et al., 1994; Gubitz et al., 1996) . However, A 2A receptor agonists have also been reported to have no eect on acetylcholine release from striatal slices, other than in the presence of dopamine (Jin et al., 1993; Jin & Fredholm, 1997) . In addition few molecular studies have con®rmed the expression of A 1 receptor mRNA in these cells (Reppert et al., 1991; Rivkees et al., 1995; Dixon et al., 1996) , and the majority of attempts to detect A 2A receptor mRNA expression in striatal cholinergic neurons have failed (Schimann et al., 1991; Schimann & Vanderhaeghen, 1993; Fink et al., 1992; Svenningsson et al., 1997) . Only one in situ hybridization study has shown mRNA encoding the A 2A receptor to be expressed in some large (presumably cholinergic) striatal neurons at low abundance (Dixon et al., 1996) .
Since the discrepancies concerning adenosine receptor mRNA expression in striatal cholinergic neurons may have been due to diering sensitivities of the techniques used, we have employed a highly sensitive single cell RT ± PCR method to examine A 1 and A 2A receptor expression in these cells. In addition it is possible that the debate over the potential functional relevance of the A 2A receptor in these cells was a consequence of the dierent in vitro preparations (synaptosomes and slices) used. We have therefore also examined the ability of A 1 and A 2A receptor agonists to regulate acetylcholine release from rat brain striatal slices.
Methods

Recording and analysis
Three hundred mm thick coronal slices (male Sprague Dawley rats, 14 ± 28 days old) were prepared using a vibratome, and bathed in aCSF of the following composition (mM); NaCl 125, NaHCO 3 25, glucose 10, KCl 2.5, NaH 2 PO4 1.25, CaCl 2 2, MgCl 2 1, bubbled with 95% O 2 and 5% CO 2 gas mixture, and viewed with a Zeiss Axioskop microscope (Carl Zeiss Ltd., Welwyn Garden City, U.K.) ®tted with a x64 water-immersion objective as previously described . The electrode buer contained (in mM): K gluconate 120, NaCl 10, MgCl 2 2, EGTA 0.5, HEPES 10, Na 2 ATP 4, Na 2 GTP 0.3, pH adjusted to 7.2 with KOH. In addition 0.5 mg ml 71 glycogen (Boehringer) and RNase inhibitor (Pharmacia, 0.1 u ml 71 were included to facilitate the harvesting of RNA from the cells. All solutions were made up in diethyl pyrocarbonate treated water (to inactivate RNases). Borosilicate recording electrodes were baked (2 h, 2508C) before being pulled to a resistance of between 3 and 5 MO. Electrophysiological signals were detected using an Axopatch-1D patch-clamp ampli®er in the current clamp con®guration and were recorded onto digital audiotape for later production. Membrane signals were ®ltered at 1 kHz and were digitized at 5 kHz through a Digidata 1200A/D converter using pClamp 6.0 software (Axon Instruments Inc, CA, U.S.A.).
The cytoplasm from large cells (430 mm in one dimension) was gently aspirated under visual control into a patch-clamp recording electrode until at least 40% of the somatic cytoplasm had been collected. The electrode was then withdrawn from the cell to form an outside-out patch, or a nucleated patch, to prevent contamination on subsequent withdrawal from the slice. The contents of the electrode were forced into a microtube and reverse transcribed, subjected to 3' cDNA ampli®cation (TPEA ± PCR), and 6% of the product used in each gene speci®c PCR reaction as described in Dixon et al. (1998) with the following modi®cations. Four de®ned pentameric sequences were present at the 3' ends of the second-strand cDNA primers, each primer contained the following heel sequence at the 5' end: CTG CAT CTA TCT AAT GCT CC. The four arbitrary 3' sequences were: CGAGA, CGACA, CGTAC and ATGCG. 2.5 pg of each second strand primer were annealed at 508C to the ®rst strand cDNA, and second strand cDNA synthesis was performed at 728C for 8 min using Taq DNA polymerase (0.35 units, Perkin Elmer) at pH 8.3 using 4.5 mM MgCl 2 and 0.5 mM dNTPs. Subsequently, 1 ng of the 5' and 3' heel primers were added in 5 ml of PCR buer containing 67 mM Tris HCl (pH 8.3), 4.5 mM MgCl 2 0.5 mM dNTPs and 0.16 units of Taq and the reaction subjected to 10 cycles of 928C (2.5 min, denaturation), 608C (annealing, 1.5 min) and 728C (extension, 1 min), followed by a ®nal 10 min extension. A further 10 ng of each heel primer were then added in 20 ml of PCR buer and subjected to a further 40 rounds of PCR (conditions as before). The ®nal reaction mixture was then diluted to 100 ml with 10 mM Tris/ 0.1 mM EDTA (pH 8.1), and 6 ml samples used for subsequent gene speci®c PCR. Gene speci®c PCR was performed as described using the following primers (accession number, base number): choline acetyltransferase: forward primer (sequence from Brice et al., 1989 , 2134 ± 2155 TACTAAGCTCTGTTCCCATCCC, reverse primer 2303 ± 2285, ACCCAGGTTGCTTCCAAAC), adenosine A 1 receptor (Y12519, forward primer 2507 ± 2526; reverse primer 2637 ± 2619), adenosine A 2A receptor (L08102, forward primer 1817 ± 1835; reverse primer 1980 ± 1960), NK 1 receptor (J05097, forward primer 2991 ± 3010; reverse primer 3195 ± 3176; preproenkephalin (S49491, forward primer 1033 ± 1050; reverse primer 1180 ± 1159); preprotachykinin (M34184, forward primer 717 ± 735; reverse primer 877 ± 85). The genomic primers recognized two polymorphic repeats: STS ET3 (forward primer: GCCTGCATTCATCTTCATCTGC, reverse primer: AAAGGTGGAACTCGCCCGTTT) and STS RR1023 (forward primer: AGCCTCATCGATGCTCCTGT, reverse primer: CCAAGAGCTACCTGCACTCC).
All of the gene speci®c primers used had similar sensitivities, detecting cDNA derived from as little as 10 pg total whole brain RNA, while the genomic primers detected as little as 10 pg of rat genomic DNA.
Release experiments
Three hundred mm thick rat striatal slices, prepared as described above, were labelled with [
3 H]-choline chloride (0.2 mM, for 45 min, at 378C) and perfused with aCSF at a rate of 0.5 ml min 71 . The superfusion buer contained hemicholinium-3 (10 mM) to inhibit choline re-uptake. After an equilibration period of 45 min, samples were collected at 2 min intervals and counted for radioactivity. Release was stimulated twice in each case by inclusion of 15 mM KCl in the superfusion buer for 1.5 min. The evoked release for each stimulus was expressed as a percentage of the total amount of radiolabel present in the slice at the point at which release was evoked, and evoked release calculated by subtracting basal release from total release for each stimulus. Modulation of release was assessed by changes in the ratio of the [ 3 H]-label release between two stimuli S1 and S2 (spaced 20 min apart). In control experiments S1 and S2 both contained 15 mM KCl, but in test experiments S1 contained KCl whereas S2 contained KCl plus agonist i.e. CGS 21680 (10 nM) or R-PIA (100 nM). The receptor antagonists CSC (500 nM), DPCPX (100 nM), bicuculline (10 mM), saclofen (1 mM) and naloxone (10 mM) were included in the superfusion buer for 20 min prior to and during the second stimulus. In some experiments assessing the role of endogenous adenosine, adenosine deaminase was present in the superfusion buer 20 min prior to and during the second stimulus. However in most experiments adenosine deaminase (I u ml 71 ) was present throughout the superfusion. The identity of the released [ 3 H]-label during stimulation by 15 mM KCl (in the presence of eserine, 1 mM) was shown to be 60 ± 70% acetylcholine by thin layer chromatography (Marchbanks, 1968) , as previously found in this system (Kirkpatrick & Richardson, 1993; Preston et al., 1999) . For thin layer chromatography 0.2 ml samples were collected during superfusion (both during stimulation and basal release), 0.1 mmol of choline and acetylcholine added as carrier, and applied to thin layer cellulose chromatography plates. The plates were developed using a mobile phase of butan-1-ol, acetic acid, water and ethanol (8 : 1 : 3 : 2), and the spots containing choline and acetylcholine visualized using a spray of 4.5% potassium iodide, 0.25% platinic chloride in aqueous ethanol (1 : 1 v v 71 ). The spots were excised and the radioactivity determined in a liquid scintillation counter. Means+s.e.mean were calculated and statistical signi®cance assessed using Student's t-test.
Results
Cholinergic neurons in striatal slices were identi®ed on the basis of their size (30 mm diameter), and by their resting electrophysiological properties on membrane rupture (Kawa-guchi 1992; 1993) . Thus these cells had a resting membrane potential of 758.6+1.4 mV, and were frequently found to ®re spontaneous action potentials at a rate of 2 ± 5 Hz. These action potentials were associated with a large after hyperpolarization (of 24.1+1.3 mV), as previously observed in interneurons of this type (Kawaguchi 1992; 1993) . These cells also showed a decrease in apparent input resistance on injection of hyperpolarizing current as reported previously (Jiang & North, 1991) , and also depolarized in response to bath application of the NK 1 receptor agonist Sar 9 , Met(O 2 ) 11 Substance P, (Bell et al., 1998) . After harvesting the cytoplasmic contents of such cells, reverse transcription and TPEA ± PCR, the expression of a variety of genes was assessed in gene speci®c PCR assays. As shown in Figure 1 , the coexpression of choline acetyltransferase with the A 1 receptor was observed in 60%, and the adenosine A 2A receptor in 67% (n=15) of the cells tested. In contrast PCR primers for preproenkephalin, preprotachykinin and the genomic sequences tested consistently failed to reveal a PCR product.
Bath application of the A 1 receptor agonist R-PIA to the superfusion¯uid caused a concentration dependent small hyperpolarization of the large cholinergic neurons. Thus 10 and 100 nM R-PIA had no discernible eect on the resting membrane properties of these neurons (n=3 for each), 1 mM R-PIA caused a 3.2+1.1 mV hyperpolarization (n=8 out of 11 cells), and 5 mM R-PIA produced a 3.8+0.5 mV hyperpolarization (n=5 out of seven cells). The eects of 1 mM R-PIA were retained in the presence of 1 mM TTX (n=4, 3.1+0.5 mV hyperpolarization) and were completely blocked by preincubation of the slice with the A 1 receptor antagonist DPCPX (100 M, n=3, Figure 2 ).
The eect of the A 1 and A 2A receptors on acetylcholine release from striatal slices evoked by a submaximal concentration of KCl (15 mM) was investigated. Inclusion of the A 1 receptor antagonist (DPCPX, 100 nM) had no signi®cant eect on the release of [ 3 H]-acetylcholine. In contrast the A 2A receptor antagonist CSC (500 nM) decreased the release (Figure 3) , which suggested the action of endogenous adenosine within the slice. This was con®rmed by inclusion of adenosine deaminase (1 u ml 71 ) after the ®rst stimulus, which caused a reduction in the release of acetylcholine in the second stimulus (Figure 3) .
In an attempt to reduce the in¯uence of endogenous adenosine, adenosine deaminase was included throughout the superfusion in subsequent experiments. Under these conditions DPCPX had no signi®cant eect on acetylcholine release, although the A 1 receptor agonist R-PIA signi®cantly inhibited the release in a DPCPX sensitive manner. In contrast, the selective agonist CGS 21680 (10 nM) signi®cantly enhanced release in a CSC sensitive manner (Figure 3 ). Since the A 2A receptor has been shown to regulate striatal GABA release from striatopallidal (enkephalin containing) neurons, the eect of GABA and opioid antagonists was investigated. The enhancement of acetylcholine release by CGS 21680 was slightly, but not signi®cantly, reduced by the coadministration of bicuculline (10 mM), saclofen (1 mM) and naloxone (10 mM, Figure 3 ).
Discussion
Striatal cholinergic neurons were identi®ed on the basis of their morphology, resting electrophysiological responses (Kawaguchi, 1992; 1993) , response to the NK 1 receptor agonist (Sar 9 , Met(O 2 ) 11 ) Substance P (Bell et al., 1998) and the expression of mRNAs encoding choline acetyltransferase. In these cells mRNA encoding the A 1 receptor was detected in 60% of the neurons sampled and the A 2A receptor mRNA in 67%. These cells were shown not only to express the receptor messages but also functional receptor protein, since the A 1 receptor agonist R-PIA hyperpolarized these cells and inhibited acetylcholine release, while the A 2A receptor agonist CGS21680 increased 
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Z. Preston et al acetylcholine release. Although the majority of these cholinergic neurons express these receptors, those that were apparently negative may represent a distinct subpopulation which do not express these receptors, or alternatively that the mRNAs were below the level of detection in these cells. The discrepancy between these results and those obtained by in situ hybridization is most probably a consequence of the previously recognised low abundance of A 2A receptor mRNA in striatal cholinergic neurons (Dixon et al., 1996) , and the high sensitivity of this PCR based technique. It is unlikely that the detection of the adenosine receptors was due to contamination by other cells or genomic DNA since mRNAs encoding preproenkephalin and preprotachykinin (two genes expressed in high abundance in 90% of striatal neurons, Graybiel, 1990) were not detected in our samples, nor were two genomic STS sequences. Expression of the A 1 receptor is consistent with some previous in situ hybridization data (Dixon et al., 1996) , and with the reported ability of A 1 receptor agonists to inhibit acetylcholine release (Brown et al., 1990; Jin et al., 1993) .
In an attempt to reconcile con¯icting reports concerning the functional eects of adenosine receptors in these cells (Jin et al., 1993; Jin & Fredholm, 1997; Brown et al., 1990; Kurokawa et al., 1994) we examined the eect of selective ligands on acetylcholine release in striatal slices. Adenosine deaminase revealed a tonic endogenous adenosine tone which increased acetylcholine release, and was blocked by the presence of the A 2A receptor selective antagonist CSC. The increase in release elicited by CGS21680 was also reversed by CSC, but not by a combination of opioid and GABA receptor antagonists, suggesting that the A 2A receptor was not acting presynaptically on the GABA and enkephalin containing striatopallidal recurrent collatetral nerve terminals Mori et al., 1996) . Since these antagonists were also unable to mimic the eect of CSC on potassium stimulated release, it is probable the endogenous tone was also directly exerted on the cholinergic neuron.
The overall stimulatory action of adenosine contrasts with a tonic inhibitory eect seen in the slices of Jin et al. (1993) and Jin & Fredholm (1997) . This dierence in the action of endogenous adenosine between the two preparations may underlie the diering eects seen with selective agonists, and could perhaps be explained by dierent degrees of A 2A receptor desensitization during slice preparation.
In conclusion both A 1 and A 2A receptors are expressed in striatal cholinergic neurons where they are functionally active. H-ACh release was evoked by two 2 min pulses of 15 mM KCl spaced 20 min apart (S1 and S2) and the S2/S1 ratio are shown after subtraction of basal release. The agonists CGS21680 (10 nM) and R-PIA (100 nM) were administered during S2 only, while the antagonists CSC (500 nM), DPCPX (100 nM), bicuculline (10 mM), saclofen (1 mM) and naloxone (10 mM) were present 20 min before, and during, S2. Antags: combined administration of bicuculline, saclofen and naloxone. (A) Eect of endogenous adenosine. Results are means+s.e.mean of between four and eight experiments, each containing duplicates. AdA: adenosine deaminase present in the superfusion¯uid 20 min before and during S2 (1 u ml 71 ); *indicates signi®cantly dierent from control (P50.05). (B) Eect of adenosine receptor ligands in the presence of adenosine deaminase. Adenosine deaminase was present throughout the superfusion of the slices. Results are means+s.e.mean of between four and eight experiments each containing duplicates or triplicates. Antagonists: simultaneous administration of bicuculline (10 mM), saclofen (1 mM) and naloxone (10 mM) *indicates signi®cantly dierent from control (P50.05), **indicates signi®cantly dierent from agonist alone (P50.05).
